These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 17973932

  • 1. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
    Chan S, Edwards SR, Wyse BD, Smith MT.
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
    [Abstract] [Full Text] [Related]

  • 2. Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Edwards SR, Smith MT.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr 01; 848(2):264-70. PubMed ID: 17098487
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
    Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD.
    Clin Pharmacol Ther; 1996 Jan 01; 59(1):52-61. PubMed ID: 8549034
    [Abstract] [Full Text] [Related]

  • 4. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
    Boström E, Jansson B, Hammarlund-Udenaes M, Simonsson US.
    Rapid Commun Mass Spectrom; 2004 Jan 01; 18(21):2565-76. PubMed ID: 15468158
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague--Dawley rats: influence of streptozotocin-induced diabetes.
    Huang L, Edwards SR, Smith MT.
    Pharm Res; 2005 Sep 01; 22(9):1489-98. PubMed ID: 16132361
    [Abstract] [Full Text] [Related]

  • 6. Grapefruit juice enhances the exposure to oral oxycodone.
    Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT.
    Basic Clin Pharmacol Toxicol; 2010 Oct 01; 107(4):782-8. PubMed ID: 20406214
    [Abstract] [Full Text] [Related]

  • 7. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
    Neuvonen M, Neuvonen PJ.
    Ther Drug Monit; 2008 Jun 01; 30(3):333-40. PubMed ID: 18520605
    [Abstract] [Full Text] [Related]

  • 8. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
    Nieminen TH, Hagelberg NM, Saari TI, Pertovaara A, Neuvonen M, Laine K, Neuvonen PJ, Olkkola KT.
    Anesthesiology; 2009 Jun 01; 110(6):1371-8. PubMed ID: 19417618
    [Abstract] [Full Text] [Related]

  • 9. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
    Pantano F, Brauneis S, Forneris A, Pacifici R, Marinelli E, Kyriakou C, Pichini S, Busardò FP.
    Clin Chem Lab Med; 2017 Aug 28; 55(9):1324-1331. PubMed ID: 28080998
    [Abstract] [Full Text] [Related]

  • 10. Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients.
    Naito T, Tashiro M, Ishida T, Ohnishi K, Kawakami J.
    J Clin Pharmacol; 2013 Aug 28; 53(8):812-8. PubMed ID: 23733622
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography.
    Cheremina O, Bachmakov I, Neubert A, Brune K, Fromm MF, Hinz B.
    Biomed Chromatogr; 2005 Dec 28; 19(10):777-82. PubMed ID: 15920700
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous determination of morphine, oxycodone, morphine-3-glucuronide, and noroxycodone concentrations in rat serum by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Edwards SR, Smith MT.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan 25; 814(2):241-9. PubMed ID: 15639445
    [Abstract] [Full Text] [Related]

  • 13. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
    Fang WB, Lofwall MR, Walsh SL, Moody DE.
    J Anal Toxicol; 2013 Jan 25; 37(6):337-44. PubMed ID: 23743505
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.
    Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD.
    Clin Pharmacol Ther; 2006 May 25; 79(5):461-79. PubMed ID: 16678548
    [Abstract] [Full Text] [Related]

  • 15. Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.
    Gaudette F, Sirhan-Daneau A, St-Onge M, Turgeon J, Michaud V.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan 01; 1008():174-180. PubMed ID: 26655109
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.
    Pöyhiä R, Seppälä T, Olkkola KT, Kalso E.
    Br J Clin Pharmacol; 1992 Jun 01; 33(6):617-21. PubMed ID: 1389934
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct 01; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

  • 18. Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
    Heiskanen T, Olkkola KT, Kalso E.
    Clin Pharmacol Ther; 1998 Dec 01; 64(6):603-11. PubMed ID: 9871425
    [Abstract] [Full Text] [Related]

  • 19. Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.
    Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT.
    Drugs Aging; 2011 Jan 01; 28(1):41-50. PubMed ID: 21174486
    [Abstract] [Full Text] [Related]

  • 20. CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
    Stamer UM, Zhang L, Book M, Lehmann LE, Stuber F, Musshoff F.
    PLoS One; 2013 Jan 01; 8(3):e60239. PubMed ID: 23555934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.